Socioeconomic and Ethnic Differences in Use of Lipid-Lowering Drugs After Deregulation of Simvastatin in the UK: The Whitehall II Prospective Cohort Study

Atherosclerosis - Netherlands
doi 10.1016/j.atherosclerosis.2010.12.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Use of Antiepileptic Drugs and Lipid-Lowering Agents in the United States

Epilepsy and Behavior
NeurologyBehavioral Neuroscience
2014English

Socioeconomic Status and Subclinical Coronary Disease in the Whitehall II Epidemiological Study

PLoS ONE
Multidisciplinary
2010English

Use of Lipid Lowering Drugs in Primary Care Is Highly Variable

BMJ
1998English

Socioeconomic Differences in General Practice Consultation Rates in Patients Aged 65 and Over: Prospective Cohort Study

BMJ
1999English

Relative Contribution of Early Life and Adult Socioeconomic Factors to Adult Morbidity in the Whitehall II Study

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
2001English

Use of Lipid-Lowering Drugs in Older Adults With and Without Dementia: A Community-Based Epidemiological Study

Journal of the American Geriatrics Society
GerontologyGeriatrics
2002English

Rilpivirine Use in the Swiss HIV Cohort Study: A Prospective Cohort Study

BMC Infectious Diseases
Infectious Diseases
2017English

Socioeconomic Gradient in Body Size and Obesity Among Women: The Role of Dietary Restraint, Disinhibition and Hunger in the Whitehall II Study

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2003English

Socioeconomic Gradient in Morbidity and Mortality in People With Diabetes: Cohort Study Findings From the Whitehall Study and the WHO Multinational Study of Vascular Disease in Diabetes

BMJ
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy